XML 116 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK BASED COMPENSATION
12 Months Ended
Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK BASED COMPENSATION
STOCK BASED COMPENSATION
The Company has the following stock based plans, all of which have been approved by the Company’s Board of Directors and shareholders:
1996 Nonemployee Directors’ Stock Option Plan (“1996 Plan”)
1997 Employee Stock Option Plan (“1997 Plan”)
2005 Amended and Restated Employee Stock Plan (“2005 Plan”)
2006 Nonemployee Director Stock Plan (“2006 Plan”)
2010 Nonemployee Director Stock Plan (“2010 Plan”)
The following table presents the amount of cumulatively granted stock options and restricted stock awards, net of forfeitures, through December 31, 2013:
 
 
Authorized
Stock
Option Awards
 
Authorized
Restricted
Stock Awards
 
Total
 
Cumulative Granted, Net of
Forfeitures
 
Total
 
Authorized
but
Unissued
 
Stock
Option  Awards
 
Restricted
Stock  Awards
 
 
 
1996 Plan
300,000

 
N/A
 
300,000

 
190,000

 
N/A

 
190,000

 
(4)

 
1997 Plan
1,100,000

 
N/A
 
1,100,000

 
972,771

 
N/A

 
972,771

 
(4)

 
2005 Plan
(1)

 
(1)
 
1,650,000

 
537,941

 
465,856

 
1,003,797

 
646,203

 
2006 Plan
(2)

 
(2)
 
35,400

 
15,000

 
20,400

 
35,400

 
(4)

 
2010 Plan
(3)

 
(3)
 
314,600

 
27,000

 
56,300

 
83,300

 
231,300

 
(1)
The Company may award up to a total of 1,650,000 shares as stock options or restricted stock awards.
(2)
The Company may award up to a total of 50,000 shares as stock options or restricted stock awards. During 2010, the remaining 14,600 shares were transferred and available for issue under the 2010 Plan.
(3)
The Company may award up to a total of 314,600 shares as stock options or restricted stock awards, inclusive of 14,600 shares which were transferred from the 2006 Plan.
(4)
There are no shares available for grant under the 1996 Plan or 1997 Plan due to their expirations. These Plans have outstanding stock options exercisable despite the Plan expiration. Additionally, the 2006 Plan has outstanding stock options exercisable despite the transfer of remaining authorized shares to the 2010 Plan.
The Company issues shares for stock option exercises and restricted stock awards from its pool of authorized but unissued shares.
The following table presents the pre-tax expense associated with stock option and restricted stock awards and the related tax benefits recognized for the years presented:
 
Years Ended December 31
 
2013
 
2012
 
2011
 
(Dollars in thousands)
Stock based compensation expense
 
 
 
 
 
Stock options
$
241

 
$
526

 
$
662

Restricted stock awards(1)
1,906

 
1,968

 
1,502

Directors’ fee expense
 
 
 
 
 
Stock options
27

 
19

 
65

Restricted stock awards
289

 
332

 
254

Total stock based award expense
$
2,462

 
$
2,845

 
$
2,483

Related tax benefits recognized in earnings
$
832

 
$
932

 
$
1,014

(1)
Inclusive of compensation expense associated with time-vested and performance-based restricted stock awards.
Amounts recognized related to awards issued to directors are recognized as directors’ fees within other noninterest expense.
The Company has standard form agreements used for stock option and restricted stock awards. The standard form agreements used for the Chief Executive Officer and all other Executive Officers have previously been disclosed in Securities and Exchange Commission filings and generally provide that: (1) any unvested options or unvested restricted stock vest upon a Change of Control; and, that (2) any stock options which vest pursuant to a Change of Control, which is an event described in Section 280G of the Internal Revenue Code of 1986, will be cashed out at the difference between the acquisition price and the exercise price of the stock option.
Stock Options
The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the following assumptions used for grants under the identified plans:
Expected volatility is based on the standard deviation of the historical volatility of the weekly adjusted closing price of the Company’s shares for a period equivalent to the expected life of the option.
Expected life represents the period of time that the option is expected to be outstanding, taking into account the contractual term, historical exercise/forfeiture behavior, and the vesting period, if any.
Expected dividend yield is an annualized rate calculated using the most recent dividend payment at time of grant and the Company’s average trailing twelve-month daily closing stock price.
The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for a period equivalent to the expected life of the option.
The stock based compensation expense recognized in earnings should be based on the amount of awards ultimately expected to vest, therefore a forfeiture assumption is estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Stock based compensation expense recognized in 2013, 2012, and 2011 has been reduced for annualized estimated forfeitures of 3.5%, 3.5%, and 5.0%, respectively, based on historical experience.
The Company has made the following awards of nonqualified options to purchase shares of common stock from 2011 through 2013:
 
Years Ended December 31
 
2013
 
2011
Date of grant
11/9/2013

 
2/10/2011
 
2/17/2011
 
5/24/2011
Plan
2010

 
2005
 
2005
 
2010
Options granted
5,000

 
40,000
 
54,000
 
7,000
Vesting period (1)
13 months

 
3 years
 
3 years
 
20 months
Expiration date
11/9/2023

 
2/10/2021
 
2/17/2021
 
5/24/2021
Expected volatility
31.23
%
 
32.38%
 
32.11%
 
32.95%
Expected life (years)
5.5

 
5.5
 
5
 
5
Expected dividend yield
2.64
%
 
2.90%
 
2.89%
 
2.87%
Risk free interest rate
1.56
%
 
2.57%
 
2.27%
 
1.81%
Fair value per option
$
8.13

 
$
6.81

 
$
6.39

 
$
6.72

 
(1)
Vesting periods begin on the grant date unless otherwise noted.
Under all of the Company’s stock based plans, the option exercise price is based upon the average of the high and low trading value of the stock on the date of grant. Stock option awards granted to date under all plans expire through 2023.
The following table presents relevant information relating to the Company’s stock options for the periods indicated:
 
Years Ended December 31
 
2013
 
2012
 
2011
 
(Dollars in thousands)
Fair value of stock options vested based on grant date fair value
$
430

 
$
706

 
$
506

Intrinsic value of stock options exercised
1,051

 
609

 
943

Cash received from stock option exercises
2,475

 
1,242

 
4,127

Tax benefit realized on stock option exercises/repurchase
322

 
242

 
735

Weighted average grant date fair value of options granted (per share)
8.13

 

 
6.58

Cash paid to settle equity instruments granted under stock based compensation arrangements

 
134

 


A summary of the status of the Company’s Stock Option Grants for the year ended December 31, 2013 is presented in the table below:
 
Outstanding
 
Nonvested
 
 
 
Stock Option
Awards
 
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term (years)
 
Aggregate
Intrinsic
Value (1)
 
Stock
Option
Awards
 
 
Weighted
Average
Grant Date
Fair Value
 
 
 
(Dollars in thousands, except per share data)
 
 
Balance at January 1, 2013
684,241

  
 
$
30.13

 
 
 
 
 
99,184

 
 
$
6.23

 
 
Granted
5,000

  
 
35.48

 
 
 
 
 
5,000

 
 
8.13

 
 
Exercised
(152,793
)
 
 
28.94

 
 
 
 
 
n/a

 
 
n/a

 
 
Vested
n/a

 
 
n/a

 
 
 
 
 
(70,197
)
 
 
6.13

 
 
Forfeited
(500
)
 
 
27.58

 
 
 
 
 
(500
)
 
 
6.81

 
 
Expired
(11,000
)
 
 
31.15

 
 
 
 
 

 
 

 
 
Balance at December 31, 2013
524,948

(2)
 
$
30.50

 
3.57
 
$
4,621

 
33,487

(4)
 
$
6.71

 
 
Options outstanding and expected to vest at December 31, 2013
524,753

(2)
 
$
30.51

 
3.56
 
$
4,620

 
 
 
 
 
 
 
Options exercisable at December 31, 2013
491,461

(3)
 
$
30.65

 
3.31
 
$
4,252

 
 
 
 
 
 
 
Unrecognized compensation cost, including forfeiture estimate
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
50

Weighted average remaining recognition period (years)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.37

 
(1)
The aggregate intrinsic value in the preceding tables represents the total pre-tax intrinsic value, based on the average of the high price and low price at which the Company’s common stock traded on December 31, 2013 of $39.31 which would have been received by the option holders had they all exercised their options as of that date.
(2)
Inclusive of 25,940 stock options outstanding and expected to vest to Directors.
(3)
Inclusive of 22,667 vested stock options outstanding to Directors.
(4)
Inclusive of 3,333 nonvested stock options outstanding to Directors.










Restricted Stock
The Company grants both time-vested restricted stock awards as well as performance-based restricted stock awards. During the years ended December 31, 2013, 2012, and 2011 the Company has made the following restricted stock award grants:

Shares Granted
 
Plan
 
Fair Value (1)
 
Vesting Period
Time-vested
 
 
 
 
 
 
 
2013
 
 
 
 
 
 
 
1/16/2013
2,000

 
2005
 
$
30.48

 
Ratably over 3 years from grant date
2/14/2013
93,800

 
2005
 
31.51

 
Ratably over 5 years from grant date
5/21/2013
14,700

 
2010
 
33.17

 
At the end of 5 years from grant date(2)
2012
 
 
 
 
 
 
 
2/16/2012
89,800

 
2005
 
$
27.81

 
Ratably over 5 years from grant date
4/5/2012
1,000

 
2005
 
28.16

 
Ratably over 5 years from grant date
5/22/2012
1,000

 
2010
 
27.63

 
Immediate upon grant
5/22/2012
13,000

 
2010
 
27.63

 
At the end of 5 years from grant date(2)
11/10/2012
1,000

 
2010
 
28.03

 
At the end of 5 years from grant date(2)
2011
 
 
 
 
 
 
 
2/10/2011
27,750

 
2005
 
$
27.58

 
Ratably over 5 years from grant date
2/17/2011
33,000

 
2005
 
27.43

 
Ratably over 5 years from grant date
5/3/2011
3,000

 
2005
 
29.00

 
Ratably over 5 years from grant date
5/24/2011
9,800

 
2010
 
28.88

 
At the end of 5 years from grant date(2)
 
 
 
 
 
 
 
 
Performance-based
 
 
 
 
 
 
 
2011
 
 
 
 
 
 
 
8/8/2011
3,637

 
2005
 
$
23.81

 
On December 31, 2014, if performance conditions are met
 
(1)
The fair value of the restricted stock awards are based upon the average of the high and low price at which the Company’s common stock traded on the date of grant. The holders of time-vested restricted stock awards participate fully in the rewards of stock ownership of the Company, including voting and dividend rights. The holders of performance-based restricted stock awards do not participate in the rewards of stock ownership of the Company until vested. The holders of all restricted stock awards are not required to pay any consideration to the Company for the awards.
(2)
These restricted stock grants will vest at the end of a five year period, or earlier if the director ceases to be a director for any reason other than cause, such as, for example, by retirement. If a non-employee director is removed from the Board for cause, the Company has ninety (90) days within which to exercise a right to repurchase any unvested portion of any restricted stock award from the non-employee director for the aggregate price of one dollar ($1.00).
The following table presents the fair value of restricted stock awards vesting during the periods presented:

 
Years Ended December 31
 
2013
 
2012
 
2011
 
(Dollars in thousands)
Fair value of restricted stock awards upon vesting
$
3,289

 
$
2,085

 
$
1,599


A summary of the status of the Company’s Restricted Stock Award Grants for the year ended December 31, 2013 is presented in the table below:
 
Outstanding Restricted Stock
Awards
 
 
Weighted Average
Grant Price ($)
 
 
 
(Dollars in thousands, except per share data)
 
 
Balance at January 1, 2013
267,761

  
 
$
25.33

 
 
Granted
110,500

  
 
31.71

 
 
Vested/released
(103,234
)
 
 
24.04

 
 
Forfeited
(3,100
)
  
 
27.57

 
 
Expired

  
 

 
 
Balance at December 31, 2013
271,927

(1)
 
$
28.39

 
 
Unrecognized compensation cost (inclusive of directors’ fees), including forfeiture estimate
 
 
 
 
 
$
5,512

Weighted average remaining recognition period (years)
 
 
 
 
 
3.37

 
(1)
Inclusive of 43,000 restricted stock awards outstanding to Directors.